Repligen (RGEN) EBITDA Margin (2010 - 2026)
Repligen (RGEN) posted EBITDA Margin of 16.18% for Q2 2026, down 2.45 percentage points from 18.63% a year earlier and down 2.19 percentage points from the prior quarter.
Repligen (RGEN) EBITDA Margin (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBITDA Margin at Repligen was 18.26%, up 10.74 percentage points year-over-year; for FY2025, it was 18.14%, up 12.69 percentage points from FY2024.
- Annual EBITDA Margin shows a five-year change of -8.31 percentage points (FY2020 to FY2025).
- In prior years, Repligen's EBITDA Margin was 5.45% in FY2024 (-12.94 pp), 18.38% in FY2023 (-16.01 pp), 34.39% in FY2022 (+3.71 pp) and 30.68% in FY2021 (+4.22 pp).
- The Q2 2026 figure stands as the lowest quarterly EBITDA Margin since Q1 2025.
- On a year-over-year basis, EBITDA Margin increased in five of the last eight quarters, with an average year-over-year change of +1.49 percentage points.
- The strongest year-over-year quarter for EBITDA Margin in the past five years was Q4 2025, with a gain of 29.93 percentage points; the weakest was Q4 2024, with a drop of 27.11 percentage points.
- According to Business Quant data, EBITDA Margin for the three prior quarters was 18.38% (Q1 2026), 19.11% (Q4 2025) and 19.51% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 249.71 Bn | 228.86 Bn | 4.88 Bn | 24.20% |
| 2 | Abbott Laboratories | 171.00 Bn | 142.08 Bn | 7.27 Bn | 21.86% |
| 3 | Danaher | 155.79 Bn | 139.61 Bn | 3.61 Bn | 28.51% |
| 4 | Intuitive Surgical | 143.91 Bn | 123.46 Bn | 1.96 Bn | 41.08% |
| 5 | Medtronic | 110.42 Bn | 76.29 Bn | 6.34 Bn | 25.55% |
| 6 | Stryker | 105.71 Bn | 91.82 Bn | 4.50 Bn | 29.67% |
| 7 | Boston Scientific | 63.26 Bn | 58.27 Bn | 3.85 Bn | 28.17% |
| 8 | Edwards Lifesciences | 49.80 Bn | 33.91 Bn | 1.35 Bn | 31.93% |
| 9 | Becton Dickinson | 48.78 Bn | 45.93 Bn | 2.32 Bn | 24.62% |
| 10 | Repligen | 10.85 Bn | 7.74 Bn | 110.04 Mn | 16.18% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16.18% |
| Mar 31, 2026 | 18.38% |
| Dec 31, 2025 | 19.11% |
| Sep 30, 2025 | 19.51% |
| Jun 30, 2025 | 18.63% |
| Mar 31, 2025 | 14.94% |
| Dec 31, 2024 | -10.82% |
| Sep 30, 2024 | 6.19% |
| Jun 30, 2024 | 14.13% |
| Mar 31, 2024 | 13.49% |
| Dec 31, 2023 | 16.28% |
| Sep 30, 2023 | 17.36% |
| Jun 30, 2023 | 22.23% |
| Mar 31, 2023 | 17.67% |
| Dec 31, 2022 | 33.85% |
| Sep 30, 2022 | 32.55% |
| Jun 30, 2022 | 36.25% |
| Mar 31, 2022 | 34.80% |
| Dec 31, 2021 | 25.98% |
| Sep 30, 2021 | 30.98% |
Repligen EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=RGEN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "RGEN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=RGEN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();